Igor Stukalin
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- CAR-T cell therapy research
-
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 18
- Cancer Immunotherapy and Biomarkers 12
- Cutaneous Melanoma Detection and Management 2
- CAR-T cell therapy research 2
-
- Renal cell carcinoma treatment 9
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Daniel Yick Chin Heng (9 shared papers)Daniel E. Meyers (15 shared papers)Aliyah Pabani (10 shared papers)Don G. Morris (8 shared papers)Vishal Navani (7 shared papers)Daniel Y.C. Heng (11 shared papers)Nimira S. Alimohamed (2 shared papers)Michelle Liane Dean (2 shared papers)
- Journals
- JAMA Network Open (3 papers)Clinical Genitourinary Cancer (2 papers)Annals of Oncology (2 papers)Gastroenterology (2 papers)European Urology Oncology (1 paper)
- Partner nations
- CanadaUnited StatesDenmark
In The Last Decade
Igor Stukalin
41 papers receiving 722 citations
Igor Stukalin's Hit Papers
Peers
Comparison fields: 5 of 63
- Oncology 299
- Pulmonary and Respiratory Medicine 254
- Cancer Research 70
- Hepatology 23
- Surgery 91
Countries citing papers authored by Igor Stukalin
This map shows the geographic impact of Igor Stukalin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Stukalin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Stukalin more than expected).
Fields of papers citing papers by Igor Stukalin
This network shows the impact of papers produced by Igor Stukalin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Stukalin. The network helps show where Igor Stukalin may publish in the future.
Co-authors
The 25 scholars most cited alongside Igor Stukalin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors Hit paper breakdown → | 2024 | 106 |
| 2 | 2016 | 70 | |
| 3 | 2019 | 66 | |
| 4 | 2022 | 55 | |
| 5 | 2020 | 44 | |
| 6 | 2021 | 40 | |
| 7 | 2021 | 40 | |
| 8 | 2016 | 38 | |
| 9 | 2016 | 35 | |
| 10 | 2021 | 27 | |
| 11 | 2019 | 26 | |
| 12 | 2023 | 22 | |
| 13 | 2021 | 16 | |
| 14 | 2018 | 12 | |
| 15 | 2018 | 11 | |
| 16 | 2021 | 11 | |
| 17 | 2022 | 11 | |
| 18 | 2023 | 11 | |
| 19 | 2020 | 10 | |
| 20 | 2024 | 10 |
About Igor Stukalin
Igor Stukalin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Economics and Econometrics, having authored 44 papers that have together received 730 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Renal cell carcinoma treatment (9 papers), Economic and Financial Impacts of Cancer (3 papers), Lung Cancer Treatments and Mutations (3 papers), Testicular diseases and treatments (3 papers), Cutaneous Melanoma Detection and Management (2 papers), Cancer Genomics and Diagnostics (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Oncology (299 citations), Pulmonary and Respiratory Medicine (254 citations), Cancer Research (70 citations), Hepatology (23 citations) and Surgery (91 citations). Igor Stukalin has collaborated with scholars based in Canada, United States and Denmark. Frequent co-authors include Daniel Yick Chin Heng, Daniel E. Meyers, Aliyah Pabani, Don G. Morris, Vishal Navani, Daniel Y.C. Heng, Nimira S. Alimohamed, Michelle Liane Dean, Tina Cheng and Siddhartha Goutam. Their work appears in journals such as JAMA Network Open, Clinical Genitourinary Cancer, Annals of Oncology, Gastroenterology and European Urology Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.